| Literature DB >> 29558201 |
Marcele F Bastos1, Ana Carolina A V Kayano1, João Luiz Silva-Filho1, João Conrado K Dos-Santos1, Carla Judice1, Yara C Blanco1, Nathaniel Shryock2, Michelle K Sercundes3, Luana S Ortolan3, Carolina Francelin4, Juliana A Leite1, Rafaella Oliveira5, Rosa M Elias6, Niels O S Câmara6, Stefanie C P Lopes1,5, Letusa Albrecht1,7, Alessandro S Farias1, Cristina P Vicente3, Claudio C Werneck8, Selma Giorgio9, Liana Verinaud4, Sabrina Epiphanio3, Claudio R F Marinho10, Pritesh Lalwani5, Rogerio Amino11, Julio Aliberti2,12, Fabio T M Costa1.
Abstract
Cerebral malaria (CM) is a multifactorial syndrome involving an exacerbated proinflammatory status, endothelial cell activation, coagulopathy, hypoxia, and accumulation of leukocytes and parasites in the brain microvasculature. Despite significant improvements in malaria control, 15% of mortality is still observed in CM cases, and 25% of survivors develop neurologic sequelae for life-even after appropriate antimalarial therapy. A treatment that ameliorates CM clinical signs, resulting in complete healing, is urgently needed. Previously, we showed a hyperbaric oxygen (HBO)-protective effect against experimental CM. Here, we provide molecular evidence that HBO targets brain endothelial cells by decreasing their activation and inhibits parasite and leukocyte accumulation, thus improving cerebral microcirculatory blood flow. HBO treatment increased the expression of aryl hydrocarbon receptor over hypoxia-inducible factor 1-α (HIF-1α), an oxygen-sensitive cytosolic receptor, along with decreased indoleamine 2,3-dioxygenase 1 expression and kynurenine levels. Moreover, ablation of HIF-1α expression in endothelial cells in mice conferred protection against CM and improved survival. We propose that HBO should be pursued as an adjunctive therapy in CM patients to prolong survival and diminish deleterious proinflammatory reaction. Furthermore, our data support the use of HBO in therapeutic strategies to improve outcomes of non-CM disorders affecting the brain.-Bastos, M. F., Kayano, A. C. A. V., Silva-Filho, J. L., Dos-Santos, J. C. K., Judice, C., Blanco, Y. C., Shryock, N., Sercundes, M. K., Ortolan, L. S., Francelin, C., Leite, J. A., Oliveira, R., Elias, R. M., Câmara, N. O. S., Lopes, S. C. P., Albrecht, L., Farias, A. S., Vicente, C. P., Werneck, C. C., Giorgio, S., Verinaud, L., Epiphanio, S., Marinho, C. R. F., Lalwani, P., Amino, R., Aliberti, J., Costa, F. T. M. Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.Entities:
Keywords: aryl-hydrocarbon receptor; brain; endothelial cell activation; tryptophan metabolism
Mesh:
Substances:
Year: 2018 PMID: 29558201 PMCID: PMC6044055 DOI: 10.1096/fj.201700844R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191